Hanmi Holdings wins US patent on immunoglobin

Hanmi Holdings said Monday it has obtained the U.S. patent entitled “A method for the mass production of immunoglobulin Fc region deleted initial methionine residues” using LAPSCOVERY Technology (Long Acting Protein/Peptide Discovery Technology).

LAPSCOVERY technology using Hanmi’s novel recombinant carrier exceeds the concept of pegylation or sustained-release formulation in maintaining the...